You are viewing South Asia


Product Overview

MEVAC™ IB VAR 2 is a live-attenuated freeze-dried monovalent vaccine for immunization against Infectious Bronchitis Virus variant-2 (GI-23).

Target Species


Respiratory Integrity Poultry

Immunization against emerging variants of Infectious Bronchitis Virus

The infectious bronchitis virus (IBV) is the cause of avian infectious bronchitis (IB), which is one of the most highly contagious diseases, resulting in many economic losses in the poultry industry worldwide.1

One emerging genotype of epidemiological importance is the GI-23 lineage (EGY VAR II-like strains) which has shown a widespread prevalence beyond the Middle East, with recent detections reported in Asia, Europe, and Africa. This spread, illustrates the ability of the GI-23 lineage to extend its geographical scope over time and emphasizes the need for comprehensive interventions at farm level.2

The use of MEVAC™ IB VAR 2 in layer and breeder flocks can help to mitigate respiratory signs and protect against egg production losses compromising food security in affected geographies.

Product Description

Composition (Before Inactivation)

  • Live attenuated avian Infectious Bronchitis virus variant-2 GI-23 [Eg/1212B] strain ≥ 3.5 log10 EID50/ dose.


For active immunization of commercial chickens against Infectious Bronchitis Virus variant-2 (GI-23).

Vaccination Program

Birds can be vaccinated from first day of age onwards, as per advice from your poultry veterinarian.


  • Onset of immunity: 2 weeks after primary vaccination.
  • Duration of immunity: until 8 weeks after single dose.
MEVAC IB VAR 2 small label mockup

Storage Precautions

  • Store and transport refrigerated (+2°C to +8°C). 
  • Do not freeze.
  • Store in a dry place protected from direct sunlight.
  • Do not use this product after the expiry date.
  • Shelf life after first opening the bottle: 3 hours.

Vaccine Preparations

  • Vaccine shall be reconstituted with sterile water free from disinfectant and/or antiseptic.
  • Shake the reconstituted lyophilisate until complete resuspension before administration.
  • Do not administer less than the recommended dosage.


Zero days.


The vaccine should be administered via the eye drop, spray, or drinking water routes.

  • Eye drop: Reconstitute 1,000 doses into 3 to 5 ml of non-chlorinated drinking water and subsequently dilute it into 30-50 ml of non-chlorinated drinking water. Use a calibrated dropper to distribute 30-50 μl-drops. Place one drop of the vaccine solution on the eye of each bird, allow the drop to spread, and release the bird.
  • Spray vaccination: Spray the vaccine solution above the birds using a spray capable of producing micro-droplets (mean diameter 80-100 μm). Make sure that birds are closely confined together during spraying. The ventilation system of the poultry house should be inoperative during the spray administration.
  • Drinking water: When using tap water, treat all water with skimmed milk powder at a rate of 2.5 g per liter to neutralize traces of chlorine. Distribute the vaccine solution at the time of use to birds. Birds should be deprived of water for two hours before vaccination.


MEVAC™ IB VAR 2 is packed and presented in vials containing a lyophilisate pellet for reconstitution (1000, 2500, 5000 doses).

Download the Product Information Sheet



1. Erfanmanesh et al (2020). Evaluation of inactivated vaccine of the variant 2 (IS-1494 /GI-23) genotype of avian infectious bronchitis. Aug; 71: 101497. Published online 2020 May 30. doi: 10.1016/j.cimid.2020.101497

2. Houta et al (2021). The emergence, evolution and spread of infectious bronchitis virus genotype GI-23. Archives of Virology (2021) 1669–26

Ready to Discuss Infectious Bronchitis Prevention?

Fill out the form below to connect with Kemin's vaccine eperts.

The content on this site is intended for informational purposes only and is not intended to be a substitute for professional veterinary advice. Although the information on this site is accessible worldwide, not all products or services are available to all persons or in all geographic locations or jurisdictions. Certain statements, product labeling and claims may differ by geography or as required by local governmental regulations.